About azenta inc. - AZTA
Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.
AZTA At a Glance
Azenta, Inc.
200 Summit Drive
Burlington, Massachusetts 01803
| Phone | 1-888-229-3682 | Revenue | 621.70M | |
| Industry | Medical/Nursing Services | Net Income | -166,985,000.00 | |
| Sector | Health Services | 2026 Sales Growth | 4.695% | |
| Fiscal Year-end | 09 / 2027 | Employees | 3,000 | |
| View SEC Filings |
AZTA Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.533 |
| Price to Book Ratio | 1.043 |
| Price to Cash Flow Ratio | 27.38 |
| Enterprise Value to EBITDA | 35.996 |
| Enterprise Value to Sales | 2.081 |
| Total Debt to Enterprise Value | 0.04 |
AZTA Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | 3.323 |
| Total Asset Turnover | 0.33 |
AZTA Liquidity
| Current Ratio | 2.675 |
| Quick Ratio | 2.344 |
| Cash Ratio | 1.428 |
AZTA Profitability
| Gross Margin | 44.228 |
| Operating Margin | -3.294 |
| Pretax Margin | -24.289 |
| Net Margin | -26.859 |
| Return on Assets | -8.379 |
| Return on Equity | -10.106 |
| Return on Total Capital | -10.894 |
| Return on Invested Capital | -9.78 |
AZTA Capital Structure
| Total Debt to Total Equity | 3.713 |
| Total Debt to Total Capital | 3.58 |
| Total Debt to Total Assets | 3.036 |
| Long-Term Debt to Equity | 3.713 |
| Long-Term Debt to Total Capital | 3.58 |